Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
11.98
+0.08 (0.67%)
At close: May 15, 2026, 4:00 PM EDT
12.00
+0.02 (0.17%)
After-hours: May 15, 2026, 7:58 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $705.36 million as of May 15, 2026. Its market cap has increased by 245.57% in one year.
Market Cap
705.36M
Enterprise Value
590.14M
1-Year Change
245.57%
Ranking
Category
Stock Price
$11.98
Market Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has increased from $110.17M to $705.36M, an increase of 540.23%. That is a compound annual growth rate of 5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 701.24M | 41.79% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 763.26M |
| Solid Biosciences | 751.17M |
| Allogene Therapeutics | 738.63M |
| Eikon Therapeutics | 713.55M |
| Crescent Biopharma | 705.45M |
| Zevra Therapeutics | 689.28M |
| BridgeBio Oncology Therapeutics | 681.08M |
| Aclaris Therapeutics | 670.39M |